Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Levi

Showing results (281-290 of 394) with videos related to

Pageof 40
Sort By:
Blood Transfusion = Trasfusione Del Sangue|February 17, 2012
Correction of subclinical coagulation disorders before percutaneous dilatational tracheotomyDenise P Veelo, Alexander P Vlaar, Dave A Dongelmans, et al.
Thrombosis Research|January 15, 2015
The cytoprotective effects of endogenous activated protein C reduce activation of coagulation during murine pneumococcal pneumonia and sepsisMarcel Schouten, Cornelis van 't Veer, Nadia Poulussen, et al.
Journal of Clinical Gastroenterology|February 10, 2010
Effect of preoperative biliary drainage on coagulation and fibrinolysis in severe obstructive cholestasisJaap J Kloek, Michal Heger, Niels A van der Gaag, et al.
Clinical and Diagnostic Laboratory Immunology|May 10, 2003
Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjectsEvert de Jonge, Philip W Friederich, George P Vlasuk, et al.
Anesthesiology|September 29, 2006
Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injuryGoda Choi, Esther K Wolthuis, Paul Bresser, et al.
Intensive Care Medicine|May 23, 2003
Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsisAnne Cornélie J M de Pont, Catherine S C Bouman, Evert de Jonge, et al.
The Journal of Infection|January 9, 2007
Procoagulant and fibrinolytic activity in cerebrospinal fluid from adults with bacterial meningitisMartijn Weisfelt, Rogier M Determann, Jan de Gans, et al.
Thrombosis and Haemostasis|October 4, 2002
Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzeesArno H M Moons, Ron J G Peters, Hugo ten Cate, et al.
Lancet (London, England)|January 28, 2003
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trialPhilip W Friederich, Christiaan P Henny, Embert J Messelink, et al.
Thrombosis and Haemostasis|October 17, 2007
The influence on INRs and coagulation factors of the time span between blood sample collection and intake of phenprocoumon or acenocoumarol: consequences for the assessment of the doseJohanna H H van Geest-Daalderop, Barbara A Hutten, Nathalie C V Péquériaux, et al.
Pageof 40

Showing results (281-290 of 394) with videos related to

Sort By:
Pageof 40
Blood Transfusion = Trasfusione Del Sangue|February 17, 2012
Correction of subclinical coagulation disorders before percutaneous dilatational tracheotomyDenise P Veelo, Alexander P Vlaar, Dave A Dongelmans, et al.
Thrombosis Research|January 15, 2015
The cytoprotective effects of endogenous activated protein C reduce activation of coagulation during murine pneumococcal pneumonia and sepsisMarcel Schouten, Cornelis van 't Veer, Nadia Poulussen, et al.
Journal of Clinical Gastroenterology|February 10, 2010
Effect of preoperative biliary drainage on coagulation and fibrinolysis in severe obstructive cholestasisJaap J Kloek, Michal Heger, Niels A van der Gaag, et al.
Clinical and Diagnostic Laboratory Immunology|May 10, 2003
Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjectsEvert de Jonge, Philip W Friederich, George P Vlasuk, et al.
Anesthesiology|September 29, 2006
Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injuryGoda Choi, Esther K Wolthuis, Paul Bresser, et al.
Intensive Care Medicine|May 23, 2003
Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsisAnne Cornélie J M de Pont, Catherine S C Bouman, Evert de Jonge, et al.
The Journal of Infection|January 9, 2007
Procoagulant and fibrinolytic activity in cerebrospinal fluid from adults with bacterial meningitisMartijn Weisfelt, Rogier M Determann, Jan de Gans, et al.
Thrombosis and Haemostasis|October 4, 2002
Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzeesArno H M Moons, Ron J G Peters, Hugo ten Cate, et al.
Lancet (London, England)|January 28, 2003
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trialPhilip W Friederich, Christiaan P Henny, Embert J Messelink, et al.
Thrombosis and Haemostasis|October 17, 2007
The influence on INRs and coagulation factors of the time span between blood sample collection and intake of phenprocoumon or acenocoumarol: consequences for the assessment of the doseJohanna H H van Geest-Daalderop, Barbara A Hutten, Nathalie C V Péquériaux, et al.
Pageof 40